Digest Network How does it work
Network
/
Society
Fr
Not verified

Fresenius Kabi

What we write about

BiotechnologyHealthIndustriaPharmaceuticalsSanità

32 Press releases

View all press releases
18/12/2025
Fresenius Kabi Introduces First-Ever Rocuronium Bromide Injection Stable at Room Temperature
Source
Fresenius Kabi
Issuer
Business Wire
1.00
0
02/12/2025
Fresenius Kabi Expands Operating Room Portfolio with New Simplist® Prefilled Syringes
Source
Fresenius Kabi
Issuer
Business Wire
1.00
0
24/11/2025
Fresenius Kabi Introduces Dalbavancin for Injection (for single-dose regimen use only)
Source
Fresenius Kabi
Issuer
Business Wire
1.00
0
12/11/2025
Industria
Medicine - various
Biotechnology
Biology
Sanità
Pharmaceuticals
Health
Oncology
Fresenius Kabi’s Adaptive Nomogram used on Aurora Xi Plasmapheresis System Now Operating Nationwide at BioLife Plasma Centers
Source
Fresenius Kabi
Issuer
Business Wire
1.00
0
12/11/2025
CORRECTING and REPLACING Fresenius Kabi Issues Voluntary Nationwide Recall of Three Lots of Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL Fill in a 2 mL Vial Due to Out-of-Specification Endotoxin Results in Certain Reserve Samples
Source
Fresenius Kabi
Issuer
Business Wire
1.00
0
07/11/2025
Fresenius Kabi Issues Voluntary Nationwide Recall of Three Lots of Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL Fill in a 2 mL Vial Due to Out-of-Specification Endotoxin Results in Certain Reserve Samples
Source
Fresenius Kabi
Issuer
Business Wire
1.00
0
29/10/2025
Industria
Biotechnology
Food hygiene
Health
Pharmaceuticals
Oncology
FDA Grants Interchangeable Designation to Fresenius Kabi’s Biosimilars Conexxence® and Bomyntra® (denosumab-bnht)
Source
Fresenius Kabi
Issuer
Business Wire
1.00
0
22/10/2025
Multimedia
Medical and health
Sanità
Health
Eventi
Fresenius Kabi Announces 13 New Inductees Into the National Blood Donation Hall of Fame
Source
Fresenius Kabi
Issuer
Business Wire
1.00
0
29/09/2025
Biotechnology
Health
Pharmaceuticals
Sanità
Industria
CMS Grants Fresenius Kabi Permanent, Product-Specific Q-Code for Conexxence® and Bomyntra® (denosumab-bnht)
Source
Fresenius Kabi
Issuer
Business Wire
1.00
0
25/09/2025
Eventi
Medical and health
Health
Sanità
Pharmaceuticals
Biotechnology
Fresenius Kabi Receives Two Major Awards for Supply and Service Excellence from Vizient®
Source
Fresenius Kabi
Issuer
Business Wire
1.00
0

Contact details

Social Media

Followers
0
Compatibility
0